AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27

Authors: Koomagi, R Zintl, F Sauerbrey, A Volm, M
Citation: R. Koomagi et al., Vascular endothelial growth factor in newly diagnosed and recurrent childhood acute lymphoblastic leukemia as measured by real-time quantitative polymerase chain reaction, CLIN CANC R, 7(11), 2001, pp. 3381-3384

Authors: Hamilton, A Volm, M
Citation: A. Hamilton et M. Volm, Nonsteroidal and steroidal aromatase inhibitors in breast cancer, ONCOLOGY-NY, 15(8), 2001, pp. 965-972

Authors: Holkova, B Takeshita, K Cheng, DM Volm, M Wasserheit, C Demopoulos, R Chanan-Khan, A
Citation: B. Holkova et al., Effect of highly active antiretroviral therapy on survival in patients with AIDS-associated pulmonary Kaposi's sarcoma treated with chemotherapy, J CL ONCOL, 19(18), 2001, pp. 3848-3851

Authors: Volm, M Mattern, J Koomagi, R
Citation: M. Volm et al., Angiostatin expression in non-small cell lung cancer, CLIN CANC R, 6(8), 2000, pp. 3236-3240

Authors: Volm, M Koomagi, R
Citation: M. Volm et R. Koomagi, Prognostic relevance of c-Myc and caspase-3 for patients with non-small cell lung cancer, ONCOL REP, 7(1), 2000, pp. 95-98

Authors: Volm, M Mattern, J Koomagi, R
Citation: M. Volm et al., Association of telomerase expression with successful heterotransplantationof lung cancer, INT J ONCOL, 16(1), 2000, pp. 31-35

Authors: Volm, M Rittgen, W
Citation: M. Volm et W. Rittgen, Cellular predictive factors for the drug response of lung cancer, ANTICANC R, 20(5B), 2000, pp. 3449-3458

Authors: Volm, M Koomagi, R
Citation: M. Volm et R. Koomagi, Hypoxia-inducible factor (HIF-1) and its relationship to apoptosis and proliferation in lung cancer, ANTICANC R, 20(3A), 2000, pp. 1527-1533

Authors: Koomagi, R Volm, M
Citation: R. Koomagi et M. Volm, Relationship between the expression of caspase-3 and the clinical outcome of patients with non-small cell lung cancer, ANTICANC R, 20(1B), 2000, pp. 493-496

Authors: Schneider, J Pollan, M Jimenez, E Marenbach, K Martinez, N Volm, M Marx, D Meden, H
Citation: J. Schneider et al., nm23-H1 expression defines a high-risk subpopulation of patients with early-stage epithelial ovarian carcinoma, BR J CANC, 82(10), 2000, pp. 1662-1670

Authors: Volm, M Koomagi, R
Citation: M. Volm et R. Koomagi, Relevance of proliferative and pro-apoptotic factors in non-small-cell lung cancer for patient survival, BR J CANC, 82(10), 2000, pp. 1747-1754

Authors: Mattern, J Koomagi, R Volm, M
Citation: J. Mattern et al., Biological characterization of subgroups of squamous cell lung carcinomas, CLIN CANC R, 5(6), 1999, pp. 1459-1463

Authors: Formenti, SC Symmans, WF Volm, M Skinner, K Cohen, D Spicer, D Danenberg, PV
Citation: Sc. Formenti et al., Concurrent paclitaxel and radiation therapy for breast cancer, SEM RAD ONC, 9(2), 1999, pp. 34-42

Authors: Volm, M Mattern, J Koomagi, R
Citation: M. Volm et al., Relationship of urokinase and urokinase receptor in non-small cell lung cancer to proliferation, angiogenesis, metastasis and patient survival, ONCOL REP, 6(3), 1999, pp. 611-615

Authors: Volm, M Koomagi, R
Citation: M. Volm et R. Koomagi, The implications of proliferation and apoptosis for lung cancer metastasis, ONCOL REP, 6(2), 1999, pp. 373-376

Authors: Volm, M Koomagi, R
Citation: M. Volm et R. Koomagi, Association of cyclin D1 expression in lung cancer and the smoking habits of patients, CANCER LETT, 141(1-2), 1999, pp. 147-150

Authors: Koomagi, R Mattern, J Volm, M
Citation: R. Koomagi et al., Glucose-related protein (GRP78) and its relationship to the drug-resistance proteins P170, GST-pi, LRP56 and angiogenesis in non-small cell lung carcinomas, ANTICANC R, 19(5B), 1999, pp. 4333-4336

Authors: Volm, M Zintl, F Sauerbrey, A Koomagi, R
Citation: M. Volm et al., Expression of Fas ligand in newly diagnosed childhood acute lymphoblastic leukemia, ANTICANC R, 19(4C), 1999, pp. 3399-3402

Authors: Volm, M Mattern, J Koomagi, R
Citation: M. Volm et al., Inverse correlation between apoptotic (Fas ligand, caspase-3) and angiogenic factors (VEGF, microvessel density) in squamous cell lung carcinomas, ANTICANC R, 19(3A), 1999, pp. 1669-1671

Authors: Mattern, J Koomagi, R Volm, M
Citation: J. Mattern et al., Xenotransplantability of human squamous cell lung cancer in nude mice is not affected by angiogenic factors, ANTICANC R, 19(3A), 1999, pp. 1941-1943

Authors: Sauerbrey, A Hafer, R Zintl, F Volm, M
Citation: A. Sauerbrey et al., Analysis of cyclin D1 in de novo and relapsed childhood acute lymphoblastic leukemia, ANTICANC R, 19(1B), 1999, pp. 645-649

Authors: Volm, M Koomagi, R Mattern, J
Citation: M. Volm et al., PD-ECGF, bFGF, and VEGF expression in non-small cell lung carcinomas and their association with lymph node metastasis, ANTICANC R, 19(1B), 1999, pp. 651-655

Authors: Volm, M Koomagi, R Mattern, J
Citation: M. Volm et al., Angiogenesis and cigarette smoking in squamous cell lung carcinomas: an immunohistochemical study of 28 cases, ANTICANC R, 19(1A), 1999, pp. 333-336

Authors: Koomagi, R Volm, M
Citation: R. Koomagi et M. Volm, Expression of Fas (CD95/APO-1) and Fas ligand in lung cancer, its prognostic and predictive relevance, INT J CANC, 84(3), 1999, pp. 239-243

Authors: Mattern, J Volm, M
Citation: J. Mattern et M. Volm, Role of oxygenation and vascularization in drug resistance, CYTOTECHNOL, 27(1-3), 1998, pp. 249-256
Risultati: 1-25 | 26-27